Mount Sinai’s BioMe™ Biobank Receives Accreditation from College of American Pathologists

BioMe is the only biorepository in New York State with CAP accreditation.

New York
 – November 20, 2013 /Press Release/  –– 

Mount Sinai's BioMe™ Biobank Program today announced that it has received accreditation from the College of American Pathologists (CAP), and is the first such program in New York State to achieve this honor. CAP accreditation certifies that the BioMe biorepository operates at the highest level of excellence and clinical-grade standards.

The CAP is the first organization to offer an accreditation program for biorepositories—laboratories that store biological samples such as blood plasma and DNA for research and commercial purposes. Accreditation is based on a rigorous on-site inspection, as well as a review of a biorepository's operations. There are an estimated 1,000 biorepositories in the United States, but only 23 have earned CAP accreditation since the program began in 2011. About half of those are academic biorepositories for research.

"CAP accreditation is a rare honor for an academic biorepository, and validates our commitment to providing medical researchers with the highest-quality service and samples," said Erwin Bottinger, MD, Principal Investigator of BioMe Biobank and Director of the Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai.

BioMe Biobank maintains an in-house quality assurance program to ensure that its customers—research scientists—are satisfied with the quality of the services and samples it receives.

Nearly 28,000 patients at The Mount Sinai Health System have consented to participate in the BioMe Biobank program, founded in 2007 by the hospital's Institute for Personalized Medicine. The biorepository, which stores de-identified DNA and plasma from patients' blood samples, is an important resource for medical researchers at Mount Sinai and at other medical institutions. BioMe Biobank has received Institutional Review Board approval to allow researchers to notify participants if they are eligible for a particular research study. To date, samples from BioMe Biobank have been used to study diabetes, chronic kidney disease, cardiovascular disease, dyslipidemia, multiple sclerosis, lupus, fatty liver disease, sarcoidosis, and other medical conditions.

# # #

About the College of American Pathologists
The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world's largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care. More information about the CAP can be found at

About the Charles Bronfman Institute for Personalized Medicine
Mount Sinai created The Charles Bronfman Institute for Personalized Medicine (IPM) to drive innovation in the data-driven and gene-based individualization of healthcare. The Institute's groundbreaking work led to the creation of the BioMe Biobank Program to enable innovation in personalized healthcare. Nearly 28,000 patients from The Mount Sinai Hospital and Mount Sinai Doctors Faculty Practice have enrolled in the BioMe program, which helps them receive more targeted, personalized care in real-time – based on their own DNA – through Mount Sinai's electronic medical record (EMR) system. Our EMR-linked personalized medicine system, called CLIPMERGE, empowers participating BioMe patients by providing tailored information in data-driven, gene-based personalized healthcare. This information includes each enrolled patient's unique genetic information and clinical data.

About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit
Find Mount Sinai on:
Twitter: @mountsinainyc